Evaluating Tumor Heterogeneity with a High Throughput Pipeline
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
drug screening
Explainable AI for Rational Antibiotic Discovery
The Scientist | Apr 24, 2024 | 1 min read
Researchers tackle the antibiotic resistance crisis with explainable neural networks and high throughput drug discovery.
Organoids: The New Frontier
The Scientist | Nov 22, 2023 | 1 min read
Explore the latest in organoid production for studying development, disease, and drug screening.
Advancing Drug Discovery by Employing Synthetic Biology Tools
The Scientist | Oct 18, 2023 | 1 min read
In this webinar, learn about the origins of artificial gene circuits and how researchers currently use synthetic biology strategies to uncover new drugs.
Simplifying the Search for Drug Targets
Aparna Nathan, PhD | Aug 1, 2023 | 3 min read
A new machine learning model promises fast prediction of drug-target interactions.